Symbol | Exchange | Currency |
|---|
By Nate Raymond and Brendan Pierson (Reuters) - Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive...
By Nate Raymond and Brendan Pierson (Reuters) - Four drugmakers, including Johnson & Johnson (NYSE:JNJ) and Teva Pharmaceutical Industries (NYSE:TEVA) Ltd, will go to trial on...
By Jessica DiNapoli (Reuters) - Proxy adviser Glass Lewis is recommending investors reject the nearly $30 million pay package for Johnson & Johnson (NYSE:JNJ) Chief Executive Alex...
While the market has been somewhat difficult to get a read on lately, there’s still plenty of great opportunities out there for investors to consider including Cardinal...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,252.52 | 2,288.88 | 2,240.32 | -25.83 | -1.13% | 1.21M | NASDAQ | |||
| 293.45 | 313.50 | 287.20 | -18.47 | -5.92% | 14.99M | NASDAQ | |||
| 151.17 | 159.10 | 146.86 | -7.34 | -4.63% | 4.35M | NYSE | |||
| 16.09 | 16.20 | 15.81 | +0.05 | +0.31% | 654.37K | NYSE | |||
| 6.55 | 6.66 | 6.53 | +0.02 | +0.31% | 5.78M | NYSE | |||
| 41.50 | 42.78 | 37.50 | +7.68 | +22.71% | 10.36M | NASDAQ | |||
| 9.29 | 9.55 | 6.58 | +2.7900 | +42.92% | 231.43M | NASDAQ | |||
| 170.71 | 176.92 | 168.43 | +3.64 | +2.18% | 3.86M | NASDAQ | |||
| 229.35 | 234.00 | 227.82 | -0.09 | -0.04% | 11.99M | NYSE | |||
| 4.08 | 4.38 | 4.02 | -0.33 | -7.48% | 1.49M | NASDAQ | |||
| 64.31 | 67.50 | 64.08 | -3.02 | -4.49% | 16.80M | NYSE | |||
| 2.81 | 2.87 | 2.6343 | +0.1200 | +4.46% | 2.17M | NASDAQ | |||
| 9.49 | 9.64 | 9.32 | -0.02 | -0.21% | 638.60K | NYSE | |||
| 9.99 | 10.65 | 9.79 | +0.21 | +2.15% | 49.92M | NYSE | |||
| 62.10 | 62.95 | 60.51 | +0.29 | +0.47% | 845.09K | NASDAQ |
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.